{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:24:23Z","timestamp":1775129063830,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.pmr.2020.03.004","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T18:00:44Z","timestamp":1590170444000},"page":"369-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management Strategies for Spinal Cord Injury Pain Updated for the Twenty-First Century"],"prefix":"10.1016","volume":"31","author":[{"given":"Erik","family":"Shaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Saulino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pmr.2020.03.004_bib1","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1213\/01.ane.0000287643.13410.5e","article-title":"Pregabalin: its pharmacology and use in pain management","volume":"105","author":"Gajraj","year":"2007","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.pmr.2020.03.004_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jamainternmed.2019.0086","article-title":"A\u00a0clinical overview of off-label use of gabapentinoid drugs","volume":"179","author":"Goodman","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.pmr.2020.03.004_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/AJP.0000000000000675","article-title":"Efficacy and safety of pregabalin in neuropathic pain followed spinal cord injury: a review and meta-analysis of randomized controlled trials","volume":"35","author":"Yu","year":"2019","journal-title":"Clin J Pain"},{"issue":"1","key":"10.1016\/j.pmr.2020.03.004_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/papr.12146","article-title":"A\u00a0comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain","volume":"15","author":"Freynhagen","year":"2015","journal-title":"Pain Pract"},{"issue":"11","key":"10.1016\/j.pmr.2020.03.004_bib5","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/14737175.2016.1202764","article-title":"Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use","volume":"16","author":"Calandre","year":"2016","journal-title":"Expert Rev Neurother"},{"issue":"7","key":"10.1016\/j.pmr.2020.03.004_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.BRS.0000112068.16108.3A","article-title":"Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury","volume":"29","author":"Levendoglu","year":"2004","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"10.1016\/j.pmr.2020.03.004_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/10790268.2002.11753609","article-title":"Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial","volume":"25","author":"Tai","year":"2002","journal-title":"J\u00a0Spinal Cord Med"},{"issue":"6","key":"10.1016\/j.pmr.2020.03.004_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.sc.3101300","article-title":"Gabapentin for neuropathic pain following spinal cord injury","volume":"40","author":"To","year":"2002","journal-title":"Spinal Cord"},{"issue":"2","key":"10.1016\/j.pmr.2020.03.004_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00002508-200203000-00007","article-title":"Long-term use of gabapentin for treatment of pain after traumatic spinal cord injury","volume":"18","author":"Putzke","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.pmr.2020.03.004_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41394-018-0038-y","article-title":"Adverse cognitive effect of gabapentin in individuals with spinal cord injury: preliminary findings","volume":"4","author":"Shem","year":"2018","journal-title":"Spinal Cord Ser Cases"},{"issue":"7","key":"10.1016\/j.pmr.2020.03.004_bib11","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.celrep.2017.01.048","article-title":"Early administration of gabapentinoids improves motor recovery after human spinal cord injury","volume":"18","author":"Warner","year":"2017","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.pmr.2020.03.004_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/1545968315624777","article-title":"Effects of pain and pain management on motor recovery of spinal cord-injured patients: a longitudinal study","volume":"30","author":"Cragg","year":"2016","journal-title":"Neurorehabil Neural Repair"},{"issue":"3","key":"10.1016\/j.pmr.2020.03.004_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/ALN.0b013e3182a10fbf","article-title":"Intrathecal gabapentin to treat chronic intractable noncancer pain","volume":"119","author":"Rauck","year":"2013","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.pmr.2020.03.004_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.pmr.2020.03.004_bib15","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.apmr.2007.07.038","article-title":"Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury","volume":"88","author":"Rintala","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"10.1016\/j.pmr.2020.03.004_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0304-3959(01)00483-3","article-title":"Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial","volume":"96","author":"Cardenas","year":"2002","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.pmr.2020.03.004_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","article-title":"Antidepressants and pain","volume":"27","author":"Mico","year":"2006","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.pmr.2020.03.004_bib18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/10790268.2017.1415246","article-title":"Evaluating the effectiveness of antidepressant therapy adjuvant to gabapentin and pregabalin for treatment of SCI-related neuropathic pain","volume":"41","author":"McKinley","year":"2018","journal-title":"J\u00a0Spinal Cord Med"},{"issue":"2","key":"10.1016\/j.pmr.2020.03.004_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pain.2010.09.005","article-title":"Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial","volume":"152","author":"Vranken","year":"2011","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.pmr.2020.03.004_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapsychiatry.2014.2482","article-title":"Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial","volume":"72","author":"Fann","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.pmr.2020.03.004_bib21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"issue":"3","key":"10.1016\/j.pmr.2020.03.004_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1465-3362.2011.00294.x","article-title":"Increasing the benefits and reducing the harms of prescription opioid analgesics","volume":"30","author":"Hallinan","year":"2011","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"10.1016\/j.pmr.2020.03.004_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.apmr.2017.12.004","article-title":"Dose and duration of opioid use in propensity score-matched, privately insured opioid users with and without spinal cord injury","volume":"99","author":"Hand","year":"2018","journal-title":"Arch Phys Med Rehabil"},{"issue":"6","key":"10.1016\/j.pmr.2020.03.004_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.5055\/jom.2010.0042","article-title":"Current concepts in the management of opioid-induced constipation","volume":"6","author":"Walters","year":"2010","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.pmr.2020.03.004_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.expneurol.2013.03.008","article-title":"Opioid administration following spinal cord injury: implications for pain and locomotor recovery","volume":"247","author":"Woller","year":"2013","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.pmr.2020.03.004_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006146","article-title":"Opioids for neuropathic pain","author":"Eisenberg","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.pmr.2020.03.004_bib27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.apmr.2017.12.036","article-title":"Evaluating the use of Medicare Part D in the veteran population with spinal cord injury\/disorder","volume":"99","author":"Hatch","year":"2018","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2020.03.004_bib28","first-page":"CD003726","article-title":"Tramadol for neuropathic pain in adults","volume":"6","author":"Duehmke","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.pmr.2020.03.004_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AJP.0b013e31818a744d","article-title":"Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"Norrbrink","year":"2009","journal-title":"Clin J Pain"},{"issue":"6","key":"10.1016\/j.pmr.2020.03.004_bib30","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S1734-1140(09)70159-8","article-title":"Tramadol as an analgesic for mild to moderate cancer pain","volume":"61","author":"Leppert","year":"2009","journal-title":"Pharmacol Rep"},{"issue":"12","key":"10.1016\/j.pmr.2020.03.004_bib31","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1590\/s0102-865020180120000006","article-title":"Influence of tramadol on functional recovery of acute spinal cord injury in rats","volume":"33","author":"Chaves","year":"2018","journal-title":"Acta Cir Bras"},{"issue":"8","key":"10.1016\/j.pmr.2020.03.004_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/09638280110108878","article-title":"The management of pain in spasticity","volume":"24","author":"Ward","year":"2002","journal-title":"Disabil Rehabil"},{"issue":"2","key":"10.1016\/j.pmr.2020.03.004_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1185\/030079908X261113","article-title":"A\u00a0practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury","volume":"24","author":"Kamen","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pmr.2020.03.004_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12984-015-0018-4","article-title":"Facilitatory effects of anti-spastic medication on robotic locomotor training in people with chronic incomplete spinal cord injury","volume":"12","author":"Duffell","year":"2015","journal-title":"J\u00a0Neuroeng Rehabil"},{"key":"10.1016\/j.pmr.2020.03.004_bib35","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.12659\/MSM.911296","article-title":"Efficacy and safety of botulinum toxin type A in spasticity caused by spinal cord injury: a randomized, controlled trial","volume":"24","author":"Yan","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.pmr.2020.03.004_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tox.2013.02.006","article-title":"Botulinum toxins: mechanisms of action, antinociception and clinical applications","volume":"306","author":"Wheeler","year":"2013","journal-title":"Toxicology"},{"issue":"9","key":"10.1016\/j.pmr.2020.03.004_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9090260","article-title":"Botulinum toxin for the treatment of neuropathic pain","volume":"9","author":"Park","year":"2017","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.pmr.2020.03.004_bib38","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ana.24605","article-title":"Botulinum toxin type A for neuropathic pain in patients with spinal cord injury","volume":"79","author":"Han","year":"2016","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.pmr.2020.03.004_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sc.2011.126","article-title":"Efficacy and safety of lithium carbonate treatment of chronic spinal cord injuries: a double-blind, randomized, placebo-controlled clinical trial","volume":"50","author":"Yang","year":"2012","journal-title":"Spinal Cord"},{"issue":"1\u20132","key":"10.1016\/j.pmr.2020.03.004_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0304-3959(99)00249-3","article-title":"Intrathecal lithium reduces neuropathic pain responses in a rat model of peripheral neuropathy","volume":"85","author":"Shimizu","year":"2000","journal-title":"Pain"},{"issue":"3 Suppl 1","key":"10.1016\/j.pmr.2020.03.004_bib41","first-page":"a1","article-title":"Chronic Central Neuropathic Pain Significantly Reduced With Lithium Carbonate: A Case Series","volume":"98","author":"Rozak","year":"2019","journal-title":"American Journal of Physical Medicine and Rehabilitation"},{"issue":"10","key":"10.1016\/j.pmr.2020.03.004_bib42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/PHM.0b013e3181f1c4ec","article-title":"Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study","volume":"89","author":"Rintala","year":"2010","journal-title":"Am J Phys Med Rehabil"},{"issue":"2","key":"10.1016\/j.pmr.2020.03.004_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1352458511419700","article-title":"A\u00a0placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex(R) (nabiximols)","volume":"18","author":"Notcutt","year":"2012","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.pmr.2020.03.004_bib44","first-page":"984","article-title":"A\u00a0double-blind, randomized, placebo-controlled, parallel-group study of THC\/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis","volume":"260","author":"Langford","year":"2013","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.pmr.2020.03.004_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1310\/sci1802-101","article-title":"Effects of nicotine on spinal cord injury pain: a randomized, double-blind, placebo controlled crossover trial","volume":"18","author":"Richardson","year":"2012","journal-title":"Top Spinal Cord Inj Rehabil"},{"issue":"2","key":"10.1016\/j.pmr.2020.03.004_bib46","first-page":"226","article-title":"Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study","volume":"78","author":"Coffey","year":"1993","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.pmr.2020.03.004_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1525-1403.2002._2004.x","article-title":"Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin","volume":"5","author":"Ordia","year":"2002","journal-title":"Neuromudulation"},{"issue":"6","key":"10.1016\/j.pmr.2020.03.004_bib48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2217\/pmt.12.60","article-title":"The use of intrathecal baclofen in pain management","volume":"2","author":"Saulino","year":"2012","journal-title":"Pain Manag"},{"issue":"4","key":"10.1016\/j.pmr.2020.03.004_bib49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/ner.12618","article-title":"The Polyanalgesic Consensus Conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"issue":"8","key":"10.1016\/j.pmr.2020.03.004_bib50","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/ner.12524","article-title":"Intrathecal drug delivery systems (IDDS): the Implantable Systems Performance Registry (ISPR)","volume":"19","author":"Konrad","year":"2016","journal-title":"Neuromodulation"},{"issue":"2","key":"10.1016\/j.pmr.2020.03.004_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"issue":"11","key":"10.1016\/j.pmr.2020.03.004_bib52","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.sc.3102027","article-title":"Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report","volume":"45","author":"Saulino","year":"2007","journal-title":"Spinal Cord"},{"issue":"9","key":"10.1016\/j.pmr.2020.03.004_bib53","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/ejp.1445","article-title":"Ziconotide for spinal cord injury-related pain","volume":"23","author":"Brinzeu","year":"2019","journal-title":"Eur J Pain"},{"key":"10.1016\/j.pmr.2020.03.004_bib54","article-title":"Ziconitide for Managing Central Neuropathic Pain Associated With Multiple Sclerosis: A Case Series. Presented at the AAPM 2011 Annual Meeting","author":"Shaw","year":"2011","journal-title":"National Harbor"},{"issue":"1\u20133","key":"10.1016\/j.pmr.2020.03.004_bib55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0165-0173(02)00207-2","article-title":"Pain and rehabilitation after spinal cord injury: the case of sensory spasticity?","volume":"40","author":"Sjolund","year":"2002","journal-title":"Brain Res Brain Res Rev"},{"issue":"3","key":"10.1016\/j.pmr.2020.03.004_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000098744","article-title":"Epidural spinal cord stimulation in the management of spasms in spinal cord injury: a prospective study","volume":"64","author":"Barolat","year":"1995","journal-title":"Stereotact Funct Neurosurg"},{"issue":"5","key":"10.1016\/j.pmr.2020.03.004_bib57","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1525-1403.2011.00364.x","article-title":"Clinical outcomes of spinal cord stimulation (SCS) in patients with chronic spinal cord injury in Abstracts from the 10th World Congress of the International Neuromodulation Society: Spine","volume":"14","author":"Shaw","year":"2011","journal-title":"Neuromodulation"},{"issue":"2","key":"10.1016\/j.pmr.2020.03.004_bib58","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.rehab.2008.12.010","article-title":"The chronic neuropathic pain of spinal cord injury: which efficiency of neuropathic stimulation?","volume":"52","author":"Lagauche","year":"2009","journal-title":"Ann Phys Rehabil Med"},{"issue":"12 Suppl 2","key":"10.1016\/j.pmr.2020.03.004_bib59","first-page":"S286","article-title":"Oscillating field stimulation in the treatment of spinal cord injury","volume":"2","author":"Walters","year":"2010","journal-title":"PM R"},{"issue":"11","key":"10.1016\/j.pmr.2020.03.004_bib60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11916-016-0590-8","article-title":"Review of recent advances in peripheral nerve stimulation (PNS)","volume":"20","author":"Chakravarthy","year":"2016","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.pmr.2020.03.004_bib61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000434667","article-title":"Peripheral nerve stimulation for pain in extremities: an update","volume":"29","author":"Pope","year":"2015","journal-title":"Prog Neurol Surg"},{"issue":"1","key":"10.1016\/j.pmr.2020.03.004_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/10790268.2017.1293329","article-title":"Percutaneous peripheral nerve stimulation for treatment of shoulder pain after spinal cord injury: a case report","volume":"41","author":"Mehech","year":"2018","journal-title":"J\u00a0Spinal Cord Med"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965120300231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965120300231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:42:20Z","timestamp":1760931740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965120300231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1047965120300231"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2020.03.004","relation":{},"ISSN":["1047-9651"],"issn-type":[{"value":"1047-9651","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management Strategies for Spinal Cord Injury Pain Updated for the Twenty-First Century","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2020.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}